If you could vote on Brexit now which option would you choose?
   

India's first COVID-19 vaccine candidate approved for human trials


Bharat Biotech’s COVID-19 vaccine has been approved for human trials, making it India’s first domestic candidate to get the green light from the government’s drug regulator as cases surge in a country with more than 1.3 billion people. The Drug Controller General of India has approved the company’s application to conduct a Phase I and II clinical trial of Covaxin, which was developed along with the Indian Council of Medical Research’s National Institute of Virology, the company said in a statement on Monday. Human clinical trials are scheduled to start across the country in July for the vaccine, which was developed and manufactured in Bharat Biotech’s facility at Genome Valley in Hyderabad, India. India, which lags only the United States, Brazil and Russia in total cases, reported close to 20,000 new infections on Monday, according to data from the country’s federal Health Ministry.

Reuters - June 30, 2020

View the full story here: https://uk.reuters.com/article/uk-health-coronavirus-india-vaccine/indias-first-covid-19-vaccine-candidate-approved-for-human-trials-idUKKBN24108V?il=0